New Drugs
Ganaxolone
Keppra now approved in oral solution:
July 17, 2003- The U.S. Food and Drug Admonistration (FDA) has approved grape-flavored,
dye-free Keppra (levetiracetam) oral solution (100 mg/mL), providing a new option for
patients with epilepsy who prefer a liquid or cannot swallow tablets. For more
information, visit keppra.com.
Clinical Trials
ClinicalTrials.gov is a service of the U.S. National
Institutes of Health and was developed by the Library of Medicine.
Novartis Pharmaceuticals Corporation has just launched a large-scale
clinical trial for children suffering from epilepsy. Patients are needed for this clinical trial of an
investigational treatment for epilepsy in children under 4 years old:
http://etrials.novartis.com/patients/epilepsy.jsp?bmrepl000045
The NINDS has released the following finding:
Study Reveals Patterns of Gene Activity in the Mouse Nervous System
For release: Wednesday, October 29, 2003
Overview The first published data from a government-funded project provide
remarkable new insights into where specific genes are active in the mouse
nervous system during development and adulthood. Information from this
project will advance researchers' understanding of how particular genes
function in the brain and spinal cord, leading to insights about how the
nervous system works. It also may lead to new ways of preventing or treating
disorders such as Parkinson's disease, Alzheimer's, psychiatric disorders,
and drug addiction.
More information is available at: www.ninds.nih.gov